Type of securities : Common share | Effective Date : 21/04/2022 | Close Selling Date : 28/04/2022
reduce mainly on selling and administrative cost, utilities expenses and animal care expenses for instance. Furthermore, the group has assessed and cut down any unnecessary cost across the group as well as
% MB % MB % 1. Wellness and Anti-aging 128.58 40.58% 162.70 43.82% 34.12 26.54% 2. Aesthetic Innovation 96.00 30.30% 67.17 18.09% (28.83) (30.03%) 3. Companion Animal Health 80.78 25.50% 132.19 35.60
Innovation 2.94 3.03 24.11 28.39 (21.17) (87.80%) 3. Companion Animal Healthcare 43.06 44.33 25.70 30.26 17.35 67.51% 4. Livestock 3.36 3.45 3.25 3.82 0.11 3.36% Total Sales Revenue 97.13 100.00 84.93 100.00
The suspension was in connection to NMG’s submission of the financial statements for the year 2017, wherein the overstatement of revenue and accrued income in the financial statements for the year
livestock animal products, together with a rise in revenues from sales of healthcare products and aesthetic innovation products for human from Baht 224.58 million in 2018 to Baht 229.87 million or 2.36% in
the company’s readjusting of employee accrued benefits and base salary to serve the company’s strategy towards fully digitalized format as well as to encourage all employee preparing for Digital
34,000.00 163,221.19 460,465.68 Accrued interest 20,203.77 - - Short-term loans to related parties 950,000.00 10,550,000.00 - Inventories - 2,569,715.13 14,815,521.18 Other current assets - 154,675.08
in 2018, the company booked additional accrued bonuses while in the past the company paid compensation to employees only in the form of incentives. Therefore, there were both incentives and accrued